TwinBeech Capital’s Legend Biotech LEGN Stock Holding History

TwinBeech Capital’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-73,168	Closed	-$2.38M	–	841
2024 Q4	$2.38M	Buy	73,168 +41,710	+133%	+$1.73M	0.04%	315
2024 Q3	$1.53M	Buy	+31,458	New	+$1.68M	0.03%	438
2024 Q2	–	Sell	-40,239	Closed	-$2.26M	–	690
2024 Q1	$2.26M	Buy	40,239 +3,054	+8%	+$184K	0.05%	326
2023 Q4	$2.24M	Buy	+37,185	New	+$2.36M	0.04%	386
2023 Q3	–	Sell	-20,128	Closed	-$1.39M	–	784
2023 Q2	$1.39M	Buy	+20,128	New	+$1.32M	0.03%	422
2023 Q1	–	Sell	-15,973	Closed	-$797K	–	762
2022 Q4	$797K	Buy	+15,973	New	+$774K	0.02%	542
2022 Q1	–	Sell	-8,012	Closed	-$373K	–	639
2021 Q4	$373K	Buy	+8,012	New	+$406K	0.02%	452

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

TwinBeech Capital's LEGN Position: Q1 2025 in Review

TwinBeech Capital sold out of Legend Biotech (LEGN) in Q1 2025, closing a stake of 73,168 shares — an estimated $2.38M sold.

TwinBeech Capital first reported a position in LEGN in Q4 2021 and held it in 7 quarters. The position peaked at $2.38M in Q4 2024. 208 funds tracked by Wall St. Rank hold LEGN as of Q1 2025.

TwinBeech Capital reported no remaining Legend Biotech position as of Q1 2025 after selling out during the quarter.
TwinBeech Capital sold 73,168 Legend Biotech shares in Q1 2025, an estimated $2.38M.
TwinBeech Capital first reported a position in Legend Biotech in Q4 2021 and held it in 7 quarters.
TwinBeech Capital's Legend Biotech position peaked at $2.38M in Q4 2024.
208 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2025.

Based on TwinBeech Capital's 13F filing for Q1 2025, filed 15 May 2025.